NEC and Data-Driven.AI Enhance AI Medical Diagnosis
NEC Laboratories Europe and Data-Driven.AI are collaborating to enhance AI-driven medical diagnostics, focusing on early disease detection and preventive health measures. Announced in a press release, the partnership aims to improve the effectiveness of medical laboratory diagnosis by using machine learning to identify unique patterns in blood results that may require further investigation.
The collaboration leverages NEC's technology to combine blood analysis with other patient information, creating a comprehensive health profile that can predict future conditions. This approach is particularly beneficial in regions like Europe, where age-related illnesses are prevalent, and early intervention is crucial.
Data-Driven.AI's CEO, Diego Facchini, highlighted the potential of AI to revolutionize early disease detection by identifying subtle health deviations that traditional methods might overlook. The continuous refinement of AI models enhances diagnostic accuracy and predictive capabilities, representing a significant advancement in disease detection and prevention.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 24 Google Expands AI Tuberculosis Screening Across Africa and Indonesia Oct 24 Lunit and Summit Test AI Pathology for Ivonescimab Research Oct 23 Pathos AI Raises $237 Million at $3 Billion Valuation Oct 23 BioVid launches synthetic physician research platform Oct 23 NICE Recommends Five AI Tools for Prostate MRI ScansLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
AstraZeneca and Oracle Partner on AI for Clinical Trials
Lunit and Discovery Life Sciences Partner on AI Tissue Analysis
Domino Data Lab and EPAM Partner on Validated AI for Life Sciences
Boehringer Ingelheim and Microsoft to Study Digital Patient Twins
POMDOCTOR Outlines Predictive Healthcare Strategy
Daily AI Brief: the AI news that matters, in your inbox.